Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

Cited by (227)

Items 101–200 of 227

1. Astrocytic monoamine oxidase B (MAOB)–gamma-aminobutyric acid (GABA) axis as a molecular brake on repair following spinal cord injury
   Hye Yeong Lee, Jung Moo Lee, Hye Yeong Lee, Jiyeon Park, Heeyoung An, Eun Kyung Park, Sae Yeon Hwang, Sol lip Yoon, Gwang Yong Hwang, Keung Nyun Kim et al. · 2025 · Signal Transduction and Targeted Therapy
2. Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats
   Katarzyna Grychowska, Uriel López-Sánchez, Mathieu Vitalis, Geoffrey Canet, Grzegorz Satała, Agnieszka Olejarz‐Maciej, Joanna Gołębiowska, Rafał Kurczab, Wojciech Pietruś, Monika Kubacka et al. · 2023 · Journal of Medicinal Chemistry
3. Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction
   Luca Pinzi, Christian Conze, Nicolò Bisi, Gabriele Dalla Torre, Ahmed Soliman, Nanci Monteiro-Abreu, Nataliya I. Trushina, Andrea Krusenbaum, Maryam Khodaei Dolouei, Andrea Hellwig et al. · 2024 · Nature Communications
4. Exploring the Genetic Association of the ABAT Gene with Alzheimer’s Disease
   Quanzhen Zheng, Rui Bi, Min Xu, Dengfeng Zhang, Liwen Tan, Ya-Ping Lu, Yong‐Gang Yao · 2021 · Molecular Neurobiology
5. Suppressing astrocytic GABA transaminase enhances tonic inhibition and weakens hippocampal spatial memory
   Mingu Gordon Park, Jiwoon Lim, Daeun Kim, Wonseok Lee, Bo‐Eun Yoon, Changjoon Justin Lee · 2025 · Experimental & Molecular Medicine
6. Changes in astrocyte function induced by stress-induced glucocorticoid exacerbate major depressive disorder
   Beomjo Park, Gee Euhn Choi · 2025 · Progress in Neurobiology
7. In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain
   Sladjana Dukić-Stefanović, Thu Hang Lai, Magali Toussaint, Oliver Clauß, Ivana I. Jevtić, Jelena Z. Penjišević, Deana B. Andrić, Friedrich‐Alexander Ludwig, Daniel Gündel, Winnie Deuther‐Conrad et al. · 2021 · Bioorganic & Medicinal Chemistry Letters
8. Identification of differentially expressed and methylated genes and construction of a co-expression network in age-related macular degeneration
   Gaohua Liang, Wenhao Ma, Yanni Luo, Jiayang Yin, Lili Hao, Jingxiang Zhong · 2022 · Annals of Translational Medicine
9. Vitamin D Reduces GABA-Positive Astrocytes in the 5xFAD Mouse Model of Alzheimer’s Disease
   Jiseung Kang, Mincheol Park, Tae Kim · 2024 · Journal of Alzheimer's Disease
10. Dementia after Ischemic Stroke, from Molecular Biomarkers to Therapeutic Options
    Vikalpa M. Dammavalam, Deborah D. Rupert, Marcos Lanio, Zhaosheng Jin, Neil A. Nadkarni, Stella E. Tsirka, Sergio Daniel Bergese · 2024 · International Journal of Molecular Sciences
11. Multitarget 2′-hydroxychalcones as potential drugs for the treatment of neurodegenerative disorders and their comorbidities
    Fabiola Kamecki, Damijan Knez, Diego B. Carvalho, Carolina Marcucci, Marina Rademacher, Josefina Higgs, Simon Žakelj, Alejandra Marcos, Felicitas de Tezanos Pinto, Juan Andrés Abin‐Carriquiry et al. · 2021 · Neuropharmacology
12. Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment
    Dongwoo Kim, Hae Young Ko, Jee-In Chung, Yongmin Mason Park, Sangwon Lee, Seon Yoo Kim, Ji Su Kim, Joong‐Hyun Chun, Kyung‐Seok Han, Misu Lee et al. · 2023 · Neuro-Oncology
13. Phloroglucinol Derivatives Exert Anti‐Inflammatory Effects and Attenuate Cognitive Impairment in LPS‐Induced Mouse Model
    Jushin Kim, Ji Won Choi, Hyeon Jeong Kim, Byungeun Kim, Yoowon Kim, Elijah Hwejin Lee, Rium Kim, Jaehwan Kim, Jiwoo Park, Yeeun Jeong et al. · 2024 · ChemMedChem
14. Astrocyte Reactivity in Alzheimer’s Disease: Therapeutic Opportunities to Promote Repair
    Nazanin Mirzaei, Nicola Davis, Tsz Wing Chau, Magdalena Sastre · 2021 · Current Alzheimer Research
15. Evaluation of the Neuroprotective Effect of Total Glycosides of Cistanche deserticola and Investigation of Novel Brain-Targeting Natural MAO-B Inhibitors
    Xinyuan Zhai, Wenyu Xie, Muhammad Yaqoob, Feng Zhao, Hong‐Jian Zhu, Shuang Yang, Kai Wang, Xumei Wang, Hai Chao Wang, Xiaoming Wang · 2024 · ACS Chemical Neuroscience
16. Synthesis and Biological Evaluation of O6-Aminoalkyl-Hispidol Analogs as Multifunctional Monoamine Oxidase-B Inhibitors towards Management of Neurodegenerative Diseases
    Ahmed H.E. Hassan, Hyeon Jeong Kim, Keontae Park, Yeonwoo Choi, Suyeon Moon, Chae Hyeon Lee, Yeon Ju Kim, Soo Bin Cho, Min Sung Gee, Danbi Lee et al. · 2023 · Antioxidants
17. Differential Proximity of Perisynaptic Astrocytic Best1 at the Excitatory and Inhibitory Tripartite Synapses in APP/PS1 and MAOB-KO Mice Revealed by Lattice Structured Illumination Microscopy
    Heeyoung An, Wuhyun Koh, SeungHee Kang, Min‐Ho Nam, Changjoon Justin Lee · 2021 · Experimental Neurobiology
18. Neuroprotective Effects of Phenolic Constituents from Drynariae Rhizoma
    Jin Sung Ahn, Chung Hyeon Lee, Xiang‐Qian Liu, Kwang Woo Hwang, Mi Hyune Oh, So‐Young Park, Wan Kyunn Whang · 2024 · Pharmaceuticals
19. Network-Based Drug Optimization toward the Treatment of Parkinson’s Disease: NRF2, MAO-B, Oxidative Stress, and Chronic Neuroinflammation
    Pablo Duarte, Francisco J. Sanchez-Porro, Enrique Crisman, Ángel Cores, Irene Jiménez, Antonio Cuadrado, José Carlos Menéndez, Rafael M. Leon · 2025 · Journal of Medicinal Chemistry
20. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library
    Damijan Knez, Martina Hrast, Rok Frlan, Anja Hafner Pišlar, Simon Žakelj, Janko Kos, Stanislav Gobec · 2021 · Bioorganic Chemistry
21. Investigation of Anti-Alzheimer’s Mechanisms of Sarsasapogenin Derivatives by Network-Based Combining Structure-Based Methods
    Moran Zhou, Jiamin Sun, Zhuohang Yu, Zengrui Wu, Weihua Li, Guixia Liu, Lei Ma, Rui Wang, Yun Tang · 2023 · Journal of Chemical Information and Modeling
22. Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress
    Shuo Qie, Haijuan Xiong, Yaqi Liu, Chenhui Yan, Yalei Wang, Lifeng Tian, Chenguang Wang, Nianli Sang · 2024 · Cell Death and Disease
23. Astrocytic gamma-aminobutyric acid dysregulation as a therapeutic target for posttraumatic stress disorder
    Sujung J. Yoon, Woojin Won, Suji L. Lee, Kayoung Han, Eunji Ha, Juheon Lee, Seung Jae Hyeon, Yoonji Joo, Haejin Hong, Hyangwon Lee et al. · 2025 · Signal Transduction and Targeted Therapy
24. Promising selective MAO-B inhibition by sesamin, a lignan from Zanthoxylum flavum stems
    Shaymaa M. M. Mohamed, Narayan D. Chaurasiya, Nesma M. Mohamed, Soad A. L. Bayoumi, Babu L. Tekwani, Samir Anis Ross · 2020 · Saudi Pharmaceutical Journal
25. A network pharmacology-based approach to explore the therapeutic potential of Sceletium tortuosum in the treatment of neurodegenerative disorders
    Yangwen Luo, Luchen Shan, Lipeng Xu, Srinivas Patnala, Isadore Kanfer, Jiahao Li, Pei Yu, Jun Xu · 2022 · PLoS ONE
26. GABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model
    Chunxia Chen, Xihe Tang, Zhaohui Lan, Chen Wan, Hua Su, Weidong Li, Yaoxuan Li, Xing Wang Zhou, Hong Gao, Xinwei Feng et al. · 2023 · Translational research
27. Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets
    Filippo Basagni, Maria Luisa Di Paolo, Giorgio Cozza, Lisa Dalla Via, Francesca Fagiani, Cristina Lanni, Michela Rosini, Anna Minarini · 2023 · Molecules
28. KDS2010 , a reversible MAO‐B inhibitor, extends the lifetime of neural probes by preventing glial scar formation
    Uikyu Chae, Heejung Chun, Jiwoon Lim, Hyogeun Shin, Wesley Charles Smith, Ji Won Choi, Ki Duk Park, Changjoon Justin Lee, Il‐Joo Cho · 2024 · Glia
29. Discovery of novel benzimidazole derivatives as selective and reversible monoamine oxidase B inhibitors for Parkinson's disease treatment
    Yangjing Lv, Miaoliang Fan, Jiayan He, Xiaoxin Song, Jianan Guo, Bianbian Gao, Jingqi Zhang, Changjun Zhang, Yuanyuan Xie · 2024 · European Journal of Medicinal Chemistry
30. Exploring Chroman‐4‐One Derivatives as MAO‐B Inhibitors: A Comprehensive Computational Study
    Jisna Jose, Jibin K. Varughese, Nemat Ali, Abdullah F. Alasmari, Abdul Malik, Thomas Mathew · 2024 · ChemistrySelect
31. The Effects of P75NTR on Learning Memory Mediated by Hippocampal Apoptosis and Synaptic Plasticity
    Junjie Tang, Shuang Feng, Xingdong Chen, Hua Huang, Min Mao, Haiyan Wang, Sen Li, Xiu‐Min Lu, Yong‐Tang Wang · 2020 · Current Pharmaceutical Design
32. Unaltered Tonic Inhibition in the Arcuate Nucleus of Diet-induced Obese Mice
    Moonsun Sa, Jung Moo Lee, Mingu Gordon Park, Jiwoon Lim, Jong Min Joseph Kim, Wuhyun Koh, Bo‐Eun Yoon, Changjoon Justin Lee · 2022 · Experimental Neurobiology
33. Resetting the circadian clock of Alzheimer’s mice via GLP-1 injection combined with time-restricted feeding
    Yanqiong Dong, Le Cheng, Yingying Zhao · 2022 · Frontiers in Physiology
34. Neurotransmitter Systems in Alzheimer’s Disease
    Marı́a Jesús Ramı́rez-Expósito, Cristina Cueto‐Ureña, José Manuel Martı́nez-Martos · 2026 · Current Issues in Molecular Biology
35. Neuroimmune regulation of the prefrontal cortex tetrapartite synapse
    Andrea Liss, Mahum T. Siddiqi, Paige Marsland, Florence P. Varodayan · 2025 · Neuropharmacology
36. Diagnostic and therapeutic potential of tonic gamma‐aminobutyric acid from reactive astrocytes in brain diseases
    Wuhyun Koh, Changjoon Justin Lee · 2024 · Clinical and Translational Medicine
37. Design and discovery of anthranilamide derivatives as a potential treatment for neurodegenerative disorders via targeting cholinesterases and monoamine oxidases
    Sumera Zaib, Imtiaz Ali Khan, Hafiz Saqib Ali, Muhammad Tayyab Younas, Aliya Ibrar, Abdel-Basit Mohammed Al-Odayni, Abdullah A. Al‐Kahtani · 2024 · International Journal of Biological Macromolecules
38. Vital Role of Monoamine Oxidases and Cholinesterases in Central Nervous System Drug Research: A Sharp Dissection of the Pathophysiology
    Begüm Evranos Aksöz, Erkan Aksöz · 2020 · Combinatorial Chemistry & High Throughput Screening
39. PET Imaging of Monoamine Oxidase B
    E. Rodriguez-Vieitez · 2020 · Springer eBooks
40. Molecular identification of ALDH1A1 and SIRT2 in the astrocytic putrescine-to-GABA metabolic pathway
    Mridula Bhalla, Jeong Im Shin, Yeon Ha Ju, Yongmin Mason Park, Seonguk Yoo, Hyeon Beom Lee, Changjoon Justin Lee · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
41. Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B Inhibitors
    Neha Rana, Parul Grover · 2024 · CNS & Neurological Disorders - Drug Targets
42. A multi enzyme study reviewing the role of target enzymes in Alzheimer’s disease and unveiling potential inhibitors with insights on their present and future assessment
    Syed Bassam Zaki, Sahar Afzal Khan, Ruhi Ali · 2025 · Medicinal Chemistry Research
43. Synthesis, Pharmacological Evaluation, and Molecular Modeling of Phthalimide Derivatives as Monoamine Oxidase and Cholinesterase Dual Inhibitors
    Nabiha Abdullah, Fahad Hussain, Naseem Ullah, Humaira Fatima, Muhammad Afaq Tahir, Umer Rashid, Abbas Hassan · 2025 · ACS Omega
44. Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology
    Ziming Zhu, Yinbiao Zhang, Xinyue Zhang, Qiaoling Chen, Shanneng Tang, Xuan Zhou, Xiao Li, Jieying Wen, Yang Bai, Tao Zhang · 2024 · Journal of Gastrointestinal Oncology
45. Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug
    Pricila Pflüger, Patrı́cia Pereira, Marı́a Isabel Loza, Jose Manuel Brea, Dolores Viña, Amit Kumar, José Angel Fontenla · 2021 · European Journal of Pharmacology
46. Lateral Ventricular Neural Stem Cells Provide Negative Feedback to Circuit Activation Through GABAergic Signaling
    Moawiah M. Naffaa, Henry H. Yin · 2025 · Cells
47. Simultaneous Detection of MAO-B and Soluble Aβ Oligomers Based on a Bimetallic Loaded ZIF-8 Core–Shell Probe
    Yunfei Tang, Mengmeng Xiao, Tongtong Duo, Xiaowan Zhang, Ziyue Chen, Wei Wei · 2025 · ACS Applied Materials & Interfaces
48. 3-Hydroxyquinolin-2-Ones Act as Dual Inhibitors of Ferroptosis and Monoamine Oxidase B: Reducing Alzheimer’s Disease-Related Amyloid Precursor Protein and Hyperphosphorylated Tau In Vivo
    Yangjing Lv, Xiaoxin Song, Jiayan He, Xiaomeng Jiang, Liwen Lu, Miaoliang Fan, Zili Guo, Changjun Zhang, Yuanyuan Xie · 2025 · Journal of Medicinal Chemistry
49. The interaction between resilience framework and neuron-astrocyte-synapse dynamics in AD
    Hongyue Ma, Haizhen Zhao, Xinhong Feng, Fengli Gao · 2025 · Frontiers in Aging Neuroscience
50. Neuroimmune Dysfunction in Alzheimer’s Disease and Other Forms of Dementia
    Takuya Yamane, Takeshi Yoshioka, Yusuke Shimo · 2024 · Chemical and Pharmaceutical Bulletin
51. Suffruticosol B from Paeonia lactiflora Ameliorates Alzheimer's Disease Pathology by Inhibiting MAO ‐B Activity
    Jae‐Jun Heo, Young‐Eun Han, Min Soo Kim, Eunji Cheong, Chun Whan Choi, Soo‐Jin Oh · 2024 · Phytotherapy Research
52. Anti-obesity effect of irreversible MAO-B inhibitors in patients with Parkinson’s disease
    Siyu Liang, Yu Sun, Shi Chen, Hui Pan · 2024 · Nutrition and Diabetes
53. Potent inhibition of human monoamine oxidase A and B by phenolic compounds and polyunsaturated fatty acids in tobacco smoke
    Sa Weon Hong, Ali Heydari, Paris R. Watson, Paul H. Teesdale‐Spittle, Rachel Page, Peter T. Northcote, Robert A. Keyzers, Mikhail V. Vyssotski, Penelope Truman · 2025 · Chemico-Biological Interactions
54. Shining a light on liver health: advancements in fluorescence-enhanced enzyme biosensors for early disease detection
    Shifeng Liu, Yatong Yin, Shihai Liu, Congxiao Wang, Wenshe Sun, Xiaokun Hu · 2024 · Frontiers in Bioengineering and Biotechnology
55. Dual inhibition of AChE and MAO-B in Alzheimer’s disease: machine learning approaches and model interpretations
    Qinghe Hou, Yan Li · 2025 · Molecular Diversity
56. ALDH2-mediated GABA biosynthesis regulates hippocampal LTP and learning adaptability
    Qi Chen, Chenjian Miao, Si-Yuan Ge, Weibo Liang, Tiepeng Liao, Yujie Shen, Yi Lin, Shoupeng Wei, Wenwei Qian, Man Yuan et al. · 2025 · Nature Chemical Biology
57. Computational Modeling of MAO Inhibitors as Anti-Alzheimer Agents
    Gurmeet Kaur, Deepti Goyal, Bhupesh Goyal · 2023 · Neuromethods
58. Visualizing cancer-originated acetate uptake through MCT1 in reactive astrocytes demarcates tumor border and extends survival in glioblastoma patients
    Hae Young Ko, Jee-In Chung, Dongwoo Kim, Yongmin Mason Park, Han Hee Jo, Sang‐Won Lee, Seon Yoo Kim, Ji Su Kim, Joong‐Hyun Chun, Kyung‐Seok Han et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
59. Putrescine acetyltransferase (PAT/SAT1) dependent GABA synthesis in astrocytes
    Jiwoon Lim, Mridula Bhalla, Mingu Gordon Park, Wuhyun Koh, Changjoon Justin Lee · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
60. FOCUSED INSIGHTS INTO ALZHEIMER’S TREATMENT STRATEGIES: PHARMACOPHORE MODELLING, DFT STUDIES, MD SIMULATIONS AND SH-SY5Y NEUROPROTECTION OF NARINGIN
    T. J. Sindhu, Jainey Puthenveettil James, Zakiya Fathima C, Rajalakshimi Vasudevan, Shankar G. Alegaon · 2025 · International Journal of Applied Pharmaceutics
61. Microglial VRK2 Regulates Astrocytic GABA Synthesis and Tonic Inhibition in the Thalamus
    Dongsu Lee, Go Eun Ha, Yeleen Lee, Denise Lee, Jongseo Lee, Jae Ho Yoon, Leechung Chang, Kyung Won Jo, Ho‐Keun Kwon, Kyong‐Tai Kim et al. · 2025 · Glia
62. Machine Learning Assisted Exploration of Natural Monoamine Oxidase‐B Inhibitors Through Molecular Docking, Structural Dynamics and Pharmacokinetic Evaluation
    Ram Lal Shrestha, Nirmal Parajuli, Sandeep Poudel Chhetri, Ashika Tamang, Manila Poudel, M C Shiva, Aakar Shrestha, Timila Shrestha, Samjhana Bharati, Binita Maharjan et al. · 2026 · Advanced Theory and Simulations
63. Vanadium Carbide Quantum Dots Exert Efficient Anti‐Inflammatory Effects in Lipopolysaccharide‐Induced BV2 Microglia and Mice
    Zhijun He, Qiqi Yang, Xiaoqian Li, Zi Wang, Shengwu Wen, Mingjie Dong, Weiyun Zhang, Youcong Gong, Zijia Zhou, Qiong Liu et al. · 2024 · Small Science
64. Synthesis and human monoamine oxidase inhibitory activity of novel C2-, C3- and C4-substituted phthalonitriles
    Haytham Elzien Alamin Ali, Lalehan Özalp, Özkan Danış, Zafer Odabaş · 2022 · Bioorganic & Medicinal Chemistry Letters
65. β-lactolin, a Monoamine Oxidase B Inhibitory Lactopeptide, Suppresses Reactive Oxygen Species Production in Lipopolysaccharide-Stimulated Astrocytes
    Shiori Akiyama, Tatsuhiro Ayabe, Chika Takahashi, Rena Ohya, Yasuhisa Ano · 2021 · Applied Sciences
66. Selegiline, a monoamine oxidase-B inhibitor as a modulator of metabolic reprogramming for cancer therapy: a review
    Jayanth Jayachandran, Sibin Nambidi, Suresh Babu Kondaveeti, Surajit Pathak, Arunkumar Radhakrishnan, Antara Banerjee, Asim K. Dutta Roy · 2026 · Frontiers in Pharmacology
67. In silico and in vitro profiling of coumarins and flavonoids for anti-Alzheimer and antioxidant activity
    Limya Yagoup Osman, Talal Ahmed Awad, Sahar Abdalla, Mohamed Osman El-Faki, Amna Alrasheed Abuzaid Ali, Eltayeb Fadul Fadul Alla · 2024 · Pure and Applied Chemistry
68. Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson’s disease
    Damijan Knez, Fen Wang, Wen-Xiang Duan, Martina Hrast, Stanislav Gobec, Xiao-Yu Cheng, Xiaobo Wang, Cheng-Jie Mao, Chun‐Feng Liu, Rok Frlan · 2024 · Bioorganic Chemistry
69. Synthesis and evaluation of C-1-alkynyl substituted N-aryl-tetrahydroisoquinolines as multitarget cholinesterase and monoamine oxidase-B inhibitors for the treatment of Alzheimer's disease
    Dunja Jovanović, Ana Filipović, Relja V. Suručić, Lela Korićanac, Jelena J. Žakula, Bojan P. Bondžić, Aleksandra M. Bondžić · 2025 · International Journal of Biological Macromolecules
70. Design, synthesis, and biological evaluation of highly potent and selective hMAO-B inhibitors featuring a tetrahydrobenzo[f][1,4]oxazepine core
    Mingxing Zhu, Xiang-Peng Xie, Suqiang Wang, Xing Xing Zhang, Zhouling Xie, Yajun Duan, Zhiwei Zhao, Chenzhong Liao · 2025 · European Journal of Medicinal Chemistry
71. Oral KDS2010 , a Monoamine Oxidase‐B ( MAO ‐B) Inhibitor, Slows the Deterioration of Motor Coordination in Genetic SCA1 Models by Inhibiting Astrocytic MAO‐B‐Mediated Inflammation
    Dong Ho Woo, Ju‐Hyun Jeon, Hye‐Jin Ryu, Gyeong Min Lee, Hye‐Won Lim, Ki Duk Park, Kwang Lae Hoe, Sang Dal Rhee · 2025 · Journal of Neurochemistry
72. Assessing effects of microwave electromagnetic field in APP/PS1 mice by in vivo GABA-weighted imaging via variable delay multipulse-chemical exchange saturation transfer MRI
    Siqi Liu, Yan Cheng, Xiaolei Zhang, Yuanyu Shen, Shuohua Wu, Yue Chen, Dafa Shi, 庄彩玉, Beibei Chen, Yazhi Zhong et al. · 2026 · Neurochemistry International
73. Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications
    Martyna Nalepa, Aleksandra Skweres, Michał Węgrzynowicz · 2026 · Free Radical Biology and Medicine
74. Advances in Tricyclic Compounds for the Treatment of Alzheimer's Disease
    Yichun Shi, 廖心丹, Guangjun Yu · 2026 · ChemMedChem
75. How do energy metabolism disorders and neuroinflammation collectively contribute to the pathogenesis of Alzheimer’s disease?
    Yinuo Lei, Liyang Liu, Yi Tang · 2026 · Ageing Research Reviews
76. Astrocyte‐Specific Phenotyping of FAD4T as an Alzheimer's Disease Mouse Model
    Ki Jung Kim, Jae‐Hun Lee, Jiwoon Lim, Taehee Lee, Jinhyeong Joo, Mridula Bhalla, Tao Wang, Rui Feng, Changjoon Justin Lee · 2025 · Glia
77. Screening of Big Pharma’s Library against Various in-house Biological Targets
    Damijan Knez, Stanislav Gobec, Martina Hrast · 2022 · Molecules
78. Two weeks dose range-finding and four weeks repeated dose oral toxicity study of a novel reversible monoamine oxidase B inhibitor KDS2010 in cynomolgus monkeys
    Kyung‐Tai Kim, Doo‐Wan Cho, Jae‐Woo Cho, Wan‐Jung Im, Dahee Kim, Jong‐Hyun Park, Ki Duk Park, Young‐Su Yang, Su-Cheol Han · 2023 · Toxicological Research
79. The effects of rasagiline on cerebral glucose metabolism, cognition, and tau in a double-blind, placebo-controlled Phase II clinical trial in Alzheimer’s dementia
    Dawn C. Matthews, Aaron R. Ritter, Ronald G. Thomas, Randolph D. Andrews, Ana S Lukic, Carolyn Revta, Jefferson W. Kinney, Babak Tousi, James B. Leverenz, Howard M. Fillit et al. · 2020
80. Supportive Pharmacological Treatment
    Kaléu Mormino Otoni, KARLA BRUNA NOGUEIRA TORRES MORMINO, Sandna Larissa Freitas dos Santos, Maria Liliane Luciano Pereira · 2022 · Springer eBooks
81. Traversing Through the Trajectory of Pathogenic Astrocytes in Alzheimer’s Disease
    Gadde Shareena, Dileep Kumar, Dee H. Wu · 2023 · Springer eBooks
82. Synthesis, Antimicrobial, and Neuropharmacological Evaluation of Novel Benzothiazole Sulfonyl-Containing Heterocyclic Scaffolds Via Multi-Component Reactions
    Fadel T. S. Almassri, Soner Özdemir, Begüm Nurpelin Sağlık, Mahmut Ülger, H. Ali Döndaş, Cevher Altuğ · 2025 · SSRN Electronic Journal
83. Multi-Omics Analysis Reveals the Role of Tire Particles in the Mechanism of Neurodegeneration
    Chenbin Kang, Yi Chen, Kai Chen, Hongwen Zhao, Hongji Yang · 2025 · SSRN Electronic Journal
84. Deciphering key chemotherapeutic drug targets within tyrosine metabolism for breast cancer and advancing a wide-ranging diagnostic strategy
    Dan Lü, Jinsong Yan, Renliang Wu, Zilu Xie, Shuang Cao, Huanhuan Shi, Shaofeng Jiang, Yi Chen, Di Chen · 2025 · Discover Oncology
85. Research on the potential mechanisms and therapeutic drug for the co-occurrence of major depressive disorder in castration-resistant prostate cancer
    Lei Xu, Mingqiang Zhang, Menghua Shi, Xuyao Lin, Guozheng Qin, Wei En Fu, Bin Huang · 2025 · Scientific Reports
86. Additional file 3 of Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity
    Pasquale D’Acunzo, Elentina K. Argyrousi, Jonathan M. Ungania, Yohan Kim, Steven DeRosa, Monika Pawlik, Chris N. Goulbourne, Ottavio Arancio, Efrat Levy · 2024 · Figshare
87. Additional file 4 of Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity
    Pasquale D’Acunzo, Elentina K. Argyrousi, Jonathan M. Ungania, Yohan Kim, Steven DeRosa, Monika Pawlik, Chris N. Goulbourne, Ottavio Arancio, Efrat Levy · 2024 · Figshare
88. Additional file 1 of Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity
    Pasquale D’Acunzo, Elentina K. Argyrousi, Jonathan M. Ungania, Yohan Kim, Steven DeRosa, Monika Pawlik, Chris N. Goulbourne, Ottavio Arancio, Efrat Levy · 2024 · Figshare
89. Additional file 1 of Astrocytic autophagy plasticity modulates Aβ clearance and cognitive function in Alzheimer’s disease
    Kim, Suhyun, Heejung Chun, Kim, Yunha, Yeyun Kim, Uiyeol Park, Jiyeon Chu, Mridula Bhalla, Choi, Seung-Hye, Ali Yousefian-Jazi, Kim, Sojung et al. · 2024 · Figshare
90. Additional file 1 of New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation
    Mohammed Salah Ayoup, Mariam Ghanem, Abdel-Hamid, Hamida, Marwa Muhammad Abu-Serie, Aliaa A. Masoud, Ghareeb, Doaa A., Mohammed B. Hawsawi, Amr Sayed Motawi Sonousi, Asmaa E. Kassab · 2024 · Figshare
91. Additional file 2 of Mitovesicles secreted into the extracellular space of brains with mitochondrial dysfunction impair synaptic plasticity
    Pasquale D’Acunzo, Elentina K. Argyrousi, Jonathan M. Ungania, Yohan Kim, Steven DeRosa, Monika Pawlik, Chris N. Goulbourne, Ottavio Arancio, Efrat Levy · 2024 · Figshare
92. Synthesis and in Vitro Evaluation of Neurotoxicity and MAOA/B Inhibitory Effects of New Pyrrolyl-Based Furan, Substituted Furan and Indole Azomethine Derivates
    Martin Sharkov, M. Georgieva, Magdalena Kondeva-Burdina · 2026 · Acta Medica Bulgarica
93. Hétérogénéité de la réactivité astrocytaire dans la maladie d'Alzheimer
    Océane Guillemaud · 2020 · theses.fr (ABES)
94. Inducing β-hairpin and α-helix folding in peptides : design, synthesis and evaluation of α-synuclein and tau aggregation inhibitors
    Nicolò Bisi · 2023 · theses.fr (ABES)
95. Investigating the molecular signature of reactive astrocytes mediated by the JAK2- STAT3 pathway using different omics : transcriptomics and proteomics insights
    Miriam Riquelme‐Perez · 2023 · theses.fr (ABES)
96. Computationally driven design and validation of piperazine-bridged phthalimide derivatives as multifunctional agents against Alzheimer's disease
    Bharti Devi, Kailash Jangid, Pooja Temgire, Naveen Kumar, Suresh Thareja, Puneet Kumar, Vinod Kumar · 2026 · European Journal of Medicinal Chemistry
97. In-depth multimodal validation of 18F-THK5351 for imaging monoamine oxidase-B-mediated reactive astrogliosis in Alzheimer’s and related neurodegenerative diseases
    Heejung Chun, Wongu Youn, Hyunkeong Lim, Ryuichi Harada, Hae Young Ko, Jiyoung Yoon, Soo Jin Oh, Philipp Seemann, Joseph G. Pepe, Brian K. Shoichet et al. · 2026 · Experimental & Molecular Medicine
98. Exploring Disulfide Bridge as a Tool to Improve Pioglitazone’s Neuroprotective Potential: Toward the Development of Prolonged‐Acting MAO‐B/PPARγ Modulators
    Filippo Basagni, Maria Luisa Di Paolo, Antonio Laghezza, Giorgio Cozza, Francesco Piazzola, Laura Facci, Emma Marcolin, Elena Roggiolani, Luca Piemontese, Anna Minarini et al. · 2026 · ChemMedChem
99. Immunometabolic reprogramming of central and peripheral immune cells in mental disorders: mechanisms and therapeutic implications
    Kexin Lin, Peipei Wang, Shen Li, Chunling Ma, Di Wen, Xia Wang, Linchuan Liao · 2026 · Frontiers in Immunology
100. Design and synthesis of 6-benzyloxybenzo[c]thiophen-1(3H)-ones as selective monoamine oxidase-B inhibitors with antioxidant and anti-neuroinflammatory activities against Parkinson's disease
     Shiqin Cong, Ke Tang, Jingjing Li, Ruifang Gu, Chen Chen, Jingning Luo, Jing Wen, Yidan Xu, Yafang Ke, Xiuxiu Liu et al. · 2026 · European Journal of Medicinal Chemistry